Welcome to our dedicated page for Lazard news (Ticker: LAZ), a resource for investors and traders seeking the latest updates and insights on Lazard stock.
Lazard Ltd (LAZ) maintains its position as a global leader in financial advisory and asset management through strategic insights and operational excellence. This dedicated news hub provides investors with essential updates on corporate developments, market strategies, and financial performance.
Access authoritative reports on mergers & acquisitions, quarterly earnings disclosures, leadership changes, and regulatory filings. Our curated collection simplifies tracking LAZ's advisory engagements in restructuring and capital markets while monitoring its asset management division's international equity strategies.
Key updates include detailed analyses of cross-border transactions, institutional client partnerships, and operational expansions across 27 countries. Professionals rely on this resource for timely insights into LAZ's advisory role in complex corporate finance matters and its evolving position in global capital markets.
Bookmark this page for structured access to press releases and expert commentary. Regular updates ensure you remain informed about LAZ's strategic direction and industry impact without promotional bias.
Lazard Ltd (NYSE: LAZ) has appointed Prasad Parmeshwaran as a Managing Director in its Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran will primarily focus on advising clients in the biotechnology and diagnostics sectors. He brings nearly two decades of relevant experience, most recently as Managing Director at Cowen Inc. where he led the Healthcare M&A group. His expertise is expected to strengthen Lazard’s capabilities in advising on strategic transactions in the healthcare space.
Lazard Ltd (NYSE: LAZ) will announce its Q2 2022 and first-half results on July 28, 2022. The press release will be available on www.lazard.com. A conference call is scheduled for 8:00 a.m. EDT on the same day to discuss these financial results, accessible via live audio webcast or by phone. Replay options will be available post-conference. Lazard, established in 1848, is a leading financial advisory and asset management firm with operations in 40 cities across 25 countries, providing a range of financial services.
Lazard Ltd (NYSE: LAZ) reported a preliminary total of $216.6 billion in assets under management (AUM) as of June 30, 2022. The AUM reflects a decline due to market depreciation of $13.1 billion, foreign exchange losses of $3.7 billion, and net outflows totaling $2.5 billion. The average AUM for Q2 2022 was $225.7 billion, compared to $235.9 billion in May 2022.
Lazard Ltd (NYSE: LAZ) has appointed Ajay Dhankhar as Managing Director in the Healthcare Group of Financial Advisory, effective immediately. Mr. Dhankhar will act as Global Head of Medical Technology, Diagnostics, and Tools, advising clients in biopharmaceuticals and healthcare technology. With over 50 major transactions under his belt, he join from McKinsey & Company, enhancing Lazard's advisory capabilities in a growing healthcare sector.
Lazard Ltd (NYSE: LAZ) has appointed Bryce Dakin as a Managing Director in its Technology Group within Financial Advisory, effective immediately. Based in San Francisco, Dakin brings nearly three decades of experience in the semiconductor and applied technologies sectors, enhancing Lazard's service offerings. Previously, he served as Global Head of Technology Corporate Advisory at Greenhill and has a background at GCA, SoundView Technology Group, and Montgomery Securities. His expertise and extensive relationships are expected to strengthen Lazard's technology coverage.
Lazard Ltd (NYSE: LAZ) has appointed Slava Brin as a Managing Director in the Telecom, Media & Entertainment Group within Financial Advisory, effective immediately. Based in New York, Brin specializes in communications and internet infrastructure, particularly in M&A, debt, and principal investing. He joins from Truist Securities and has also worked at Evercore, contributing extensively to notable M&A transactions. This strategic addition aims to strengthen Lazard's focus on digital infrastructure.
Lazard Ltd (NYSE: LAZ) announced its preliminary assets under management (AUM) as of May 31, 2022, totaling approximately $236.0 billion. The AUM reported includes foreign exchange appreciation of $1.4 billion, market depreciation of $1.1 billion, and net outflows of $1.0 billion during the month. As of April 30, 2022, AUM was $236.6 billion. The firm's AUM consists of $187.1 billion in equity, $42.1 billion in fixed income, and $6.7 billion in other assets.
Lazard Ltd (NYSE: LAZ) announced that Kenneth M. Jacobs, Chairman and CEO, will participate in a moderated Q&A session at the Morgan Stanley U.S. Financials, Payments & CRE Conference on Tuesday, June 14, at 8:00 a.m. EDT. A live audio webcast will be available on the Lazard Investor Relations website, with a replay uploaded shortly after the conference.
Lazard, established in 1848, is a leading financial advisory and asset management firm operating in 40 cities across 25 countries, providing services such as mergers and acquisitions advice, restructuring, and capital raising.
FAQ
What is the current stock price of Lazard (LAZ)?
What is the market cap of Lazard (LAZ)?
